US 10392368
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
granted A61KA61K31/416A61P
Quick answer
US patent 10392368 (Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 46
- CPC classes
- A61K, A61K31/416, A61P, A61P1/00, A61P17/00